Amedisys Inc (AMED)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	361,900	366,900	369,900	373,200	419,400	443,400	442,400	429,500	432,100	434,800	179,400	231,400	204,500	300,600	392,700	379,900	232,256	231,600	266,500	303,700
Total assets	US$ in thousands	2,060,170	2,027,420	1,982,400	1,946,960	1,976,240	1,982,130	2,000,990	1,908,390	1,856,970	1,937,640	1,599,560	1,573,210	1,567,200	1,602,720	1,645,490	1,440,080	1,262,740	1,212,380	1,205,860	1,184,240
Debt-to-assets ratio		0.18	0.18	0.19	0.19	0.21	0.22	0.22	0.23	0.23	0.22	0.11	0.15	0.13	0.19	0.24	0.26	0.18	0.19	0.22	0.26

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $361,900K ÷ $2,060,170K
= 0.18

Amedisys Inc.'s debt-to-assets ratio has been showing a decreasing trend over the past eight quarters, decreasing from 0.23 in Q1 2022 to 0.19 in Q4 2023. This indicates that the company has been relying less on debt to finance its assets relative to its total assets over the period analyzed. A lower debt-to-assets ratio is generally viewed positively as it suggests that the company has a lower level of debt compared to its total assets, which can be indicative of a healthier financial position and lower financial risk. The decreasing trend in the debt-to-assets ratio may suggest that Amedisys Inc. has been effectively managing its debt levels and/or increasing its asset base during the period. However, it is important to note that this ratio should be analyzed in conjunction with other financial metrics to get a comprehensive understanding of the company's financial health and leverage position.